NCT06576102Completed
Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients
Evaluation of Prevalence and Risk Factors of Persistent SARS-CoV-2 Infection in Immunocompromised Patients
Source: ClinicalTrials.gov · Last updated 28 May 2026
Brief summary (registry, in English)
Spontaneous international multicenter retrospective and prospective observational study which objective is to evaluate the prevalence and risk factors of persistent SARS-CoV-2 infection within a population of hematology patients with humoral immunity deficiency.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 204 (actual)
- First submitted
- 27 Aug 2024
- Start date
- 1 Mar 2024
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- Maddalena Giannella
- NCT number
- NCT06576102
What you commit to
- Study type: Observational
- Participants enrolled: 204
- From 1 Mar 2024 to the primary completion date, 30 Sept 2024
- 5 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Diagnosis of B cell malignancies or previous treatment with B cell targeting therapies.
- Diagnosis of proven SARS-CoV-2 infection confirmed by a PCR test (only the first infection during the study period will be considered, re-infection will be counted as a secondary endpoint).
- Provision of signed and dated informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Virgen Macarena Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
| Irccs Aoubo Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
| IRCCS Humanitas Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
| IRCCS INMI L. Spallanzani Coordinator of this site? Confirm its status | Roma | Italy | Unknown status |
| AOUI Verona Coordinator of this site? Confirm its status | Verona | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.